Skip to main content
NCBI home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1995 Jan;8(1):22–33. doi: 10.1128/cmr.8.1.22

Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

V G Hemming 1, G A Prince 1, J R Groothuis 1, G R Siber 1
PMCID: PMC172847  PMID: 7704893

Abstract

Respiratory syncytial virus (RSV) is an important community and nosocomial respiratory pathogen for infants and young children. RSV causes especially severe disease in the prematurely born or those with chronic cardiopulmonary diseases. Elderly persons and those with T-cell deficiencies, such as bone marrow transplant recipients, are also at high risk for serious lower respiratory tract infections. To date, prevention of RSV infections by vaccination has proven elusive and no preventive drugs exist. Studies in animals and humans have shown that the lower respiratory tract can be protected from RSV infection by sufficient circulating RSV neutralizing antibody levels. Recently, an RSV hyperimmune immune globulin (RSVIG) was developed and tested for the prevention of RSV infections or reduction of disease severity. Passive immunization of high-risk children with RSVIG during the respiratory disease season effected significant reductions in RSV infections, hospitalizations, days of hospitalization, intensive care unit admissions, days in the intensive care unit, and ribavirin use. Studies in cotton rats and owl monkeys show that RSV infections can also be treated with inhalation of immune globulin at doses substantially smaller than required for parenteral treatment. Therapeutic trials of parenteral RSVIG have been completed and are pending analysis. The use of polyclonal, hyperimmune globulins and perhaps human monoclonal antibodies provides an additional approach to the prevention and perhaps the treatment of certain viral lower respiratory tract infections such as those caused by RSV.

Full Text

The Full Text of this article is available as a PDF (294.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abman S. H., Ogle J. W., Butler-Simon N., Rumack C. M., Accurso F. J. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediatr. 1988 Nov;113(5):826–830. doi: 10.1016/s0022-3476(88)80008-8. [DOI] [PubMed] [Google Scholar]
  2. Agius G., Dindinaud G., Biggar R. J., Peyre R., Vaillant V., Ranger S., Poupet J. Y., Cisse M. F., Castets M. An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings. J Med Virol. 1990 Feb;30(2):117–127. doi: 10.1002/jmv.1890300208. [DOI] [PubMed] [Google Scholar]
  3. Anderson L. J., Bingham P., Hierholzer J. C. Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies. J Virol. 1988 Nov;62(11):4232–4238. doi: 10.1128/jvi.62.11.4232-4238.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anderson L. J., Hendry R. M., Pierik L. T., Tsou C., McIntosh K. Multicenter study of strains of respiratory syncytial virus. J Infect Dis. 1991 Apr;163(4):687–692. doi: 10.1093/infdis/163.4.687. [DOI] [PubMed] [Google Scholar]
  5. Anderson L. J., Hierholzer J. C., Bingham P. G., Stone Y. O. Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay. J Clin Microbiol. 1985 Dec;22(6):1050–1052. doi: 10.1128/jcm.22.6.1050-1052.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Anderson L. J., Hierholzer J. C., Stone Y. O., Tsou C., Fernie B. F. Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay. J Clin Microbiol. 1986 Mar;23(3):475–480. doi: 10.1128/jcm.23.3.475-480.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Anderson L. J., Hierholzer J. C., Tsou C., Hendry R. M., Fernie B. F., Stone Y., McIntosh K. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis. 1985 Apr;151(4):626–633. doi: 10.1093/infdis/151.4.626. [DOI] [PubMed] [Google Scholar]
  8. BEEM M., EGERER R., ANDERSON J. RESPIRATORY SYNCYTIAL VIRUS NEUTRALIZING ANTIBODIES IN PERSONS RESIDING IN CHICAGO, ILLINOIS. Pediatrics. 1964 Dec;34:761–770. [PubMed] [Google Scholar]
  9. BEEM M., WRIGHT F. H., HAMRE D., EGERER R., OEHME M. Association of the chimpanzee coryza agent with acute respiratory disease in children. N Engl J Med. 1960 Sep 15;263:523–530. doi: 10.1056/NEJM196009152631101. [DOI] [PubMed] [Google Scholar]
  10. BERKOVICH S. ACUTE RESPIRATORY ILLNESS IN THE PREMATURE NURSERY ASSOCIATED WITH RESPIRATORY SYNCYTIAL VIRUS INFECTIONS. Pediatrics. 1964 Dec;34:753–760. [PubMed] [Google Scholar]
  11. BLOUNT R. E., Jr, MORRIS J. A., SAVAGE R. E. Recovery of cytopathogenic agent from chimpanzees with coryza. Proc Soc Exp Biol Med. 1956 Jul;92(3):544–549. doi: 10.3181/00379727-92-22538. [DOI] [PubMed] [Google Scholar]
  12. BURCH G. E., WALSH J. J., MOGABGAB W. A study of the response of the cardiovascular system to Asian influenza. Am Rev Respir Dis. 1961 Feb;83(2):68–78. doi: 10.1164/arrd.1961.83.2P2.68. [DOI] [PubMed] [Google Scholar]
  13. Beeler J. A., van Wyke Coelingh K. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. J Virol. 1989 Jul;63(7):2941–2950. doi: 10.1128/jvi.63.7.2941-2950.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Beem M. Repeated infections with respiratory syncytial virus. J Immunol. 1967 Jun;98(6):1115–1122. [PubMed] [Google Scholar]
  15. Belshe R. B., Anderson E. L., Walsh E. E. Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children. J Infect Dis. 1993 Oct;168(4):1024–1029. doi: 10.1093/infdis/168.4.1024. [DOI] [PubMed] [Google Scholar]
  16. Belshe R. B., Richardson L. S., London W. T., Sly D. L., Lorfeld J. H., Camargo E., Prevar D. A., Chanock R. M. Experimental respiratory syncytial virus infection of four species of primates. J Med Virol. 1977;1(3):157–162. doi: 10.1002/jmv.1890010302. [DOI] [PubMed] [Google Scholar]
  17. Belshe R. B., Van Voris L. P., Mufson M. A. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J Infect Dis. 1982 Mar;145(3):311–319. doi: 10.1093/infdis/145.3.311. [DOI] [PubMed] [Google Scholar]
  18. Brideau R. J., Walters R. R., Stier M. A., Wathen M. W. Protection of cotton rats against human respiratory syncytial virus by vaccination with a novel chimeric FG glycoprotein. J Gen Virol. 1989 Oct;70(Pt 10):2637–2644. doi: 10.1099/0022-1317-70-10-2637. [DOI] [PubMed] [Google Scholar]
  19. Bruhn F. W., Yeager A. S. Respiratory syncytial virus in early infancy. Circulating antibody and the severity of infection. Am J Dis Child. 1977 Feb;131(2):145–148. doi: 10.1001/archpedi.1977.02120150027004. [DOI] [PubMed] [Google Scholar]
  20. Buynak E. B., Weibel R. E., McLean A. A., Hilleman M. R. Live respiratory syncytial virus vaccine administered parenterally. Proc Soc Exp Biol Med. 1978 Apr;157(4):636–642. doi: 10.3181/00379727-157-40112. [DOI] [PubMed] [Google Scholar]
  21. CHANOCK R. M., KIM H. W., VARGOSKO A. J., DELEVA A., JOHNSON K. M., CUMMING C., PARROTT R. H. Respiratory syncytial virus. I. Virus recovery and other observations during 1960 outbreak of bronchiolitis, pneumonia, and minor respiratory diseases in children. JAMA. 1961 May 27;176:647–653. [PubMed] [Google Scholar]
  22. CHANOCK R. M., PARROTT R. H. ACUTE RESPIRATORY DISEASE IN INFANCY AND CHILDHOOD: PRESENT UNDERSTANDING AND PROSPECTS FOR PREVENTION. Pediatrics. 1965 Jul;36:21–39. [PubMed] [Google Scholar]
  23. CHANOCK R., FINBERG L. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children. Am J Hyg. 1957 Nov;66(3):291–300. doi: 10.1093/oxfordjournals.aje.a119902. [DOI] [PubMed] [Google Scholar]
  24. CHANOCK R., ROIZMAN B., MYERS R. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. Am J Hyg. 1957 Nov;66(3):281–290. doi: 10.1093/oxfordjournals.aje.a119901. [DOI] [PubMed] [Google Scholar]
  25. COATES H. V., KENDRICK L., CHANOCK R. M. Antigenic differences between two strains of respiratory syncytial virus. Proc Soc Exp Biol Med. 1963 Apr;112:958–964. doi: 10.3181/00379727-112-28221. [DOI] [PubMed] [Google Scholar]
  26. Cane P. A., Pringle C. R. Respiratory syncytial virus heterogeneity during an epidemic: analysis by limited nucleotide sequencing (SH gene) and restriction mapping (N gene). J Gen Virol. 1991 Feb;72(Pt 2):349–357. doi: 10.1099/0022-1317-72-2-349. [DOI] [PubMed] [Google Scholar]
  27. Chandwani S., Borkowsky W., Krasinski K., Lawrence R., Welliver R. Respiratory syncytial virus infection in human immunodeficiency virus-infected children. J Pediatr. 1990 Aug;117(2 Pt 1):251–254. doi: 10.1016/s0022-3476(05)80539-6. [DOI] [PubMed] [Google Scholar]
  28. Chanock R. M., Richardson L. S., Belshe R. B., Kim H. W., Parrott R. H. Prospects for prevention of bronchiolitis caused by respiratory syncytial virus. Pediatr Res. 1977 Mar;11(3 Pt 2):264–267. [PubMed] [Google Scholar]
  29. Chin J., Magoffin R. L., Shearer L. A., Schieble J. H., Lennette E. H. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol. 1969 Apr;89(4):449–463. doi: 10.1093/oxfordjournals.aje.a120957. [DOI] [PubMed] [Google Scholar]
  30. Coates H. V., Alling D. W., Chanock R. M. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. Am J Epidemiol. 1966 Mar;83(2):299–313. doi: 10.1093/oxfordjournals.aje.a120586. [DOI] [PubMed] [Google Scholar]
  31. Cote P. J., Jr, Fernie B. F., Ford E. C., Shih J. W., Gerin J. L. Monoclonal antibodies to respiratory syncytial virus: detection of virus neutralization and other antigen-antibody systems using infected human and murine cells. J Virol Methods. 1981 Oct;3(3):137–147. doi: 10.1016/0166-0934(81)90048-3. [DOI] [PubMed] [Google Scholar]
  32. Cristina J., López J. A., Albó C., García-Barreno B., García J., Melero J. A., Portela A. Analysis of genetic variability in human respiratory syncytial virus by the RNase A mismatch cleavage method: subtype divergence and heterogeneity. Virology. 1990 Jan;174(1):126–134. doi: 10.1016/0042-6822(90)90061-u. [DOI] [PubMed] [Google Scholar]
  33. Crowe J. E., Jr, Murphy B. R., Chanock R. M., Williamson R. A., Barbas C. F., 3rd, Burton D. R. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1386–1390. doi: 10.1073/pnas.91.4.1386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Cunningham C. K., McMillan J. A., Gross S. J. Rehospitalization for respiratory illness in infants of less than 32 weeks' gestation. Pediatrics. 1991 Sep;88(3):527–532. [PubMed] [Google Scholar]
  35. Dreizin R. S., Vyshnevetskaia L. O., Bagdamian E. E., Iankevich O. D., Tarasova L. B. Izuchenie éksperimental'noi RS virusnoi infektsii na khlopkovykh krysakh, Virusologicheskoe i immunofliuorestsentnoe issledovanie. Vopr Virusol. 1971 Nov-Dec;16(6):670–676. [PubMed] [Google Scholar]
  36. Englund J. A., Anderson L. J., Rhame F. S. Nosocomial transmission of respiratory syncytial virus in immunocompromised adults. J Clin Microbiol. 1991 Jan;29(1):115–119. doi: 10.1128/jcm.29.1.115-119.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Englund J. A., Sullivan C. J., Jordan M. C., Dehner L. P., Vercellotti G. M., Balfour H. H., Jr Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med. 1988 Aug 1;109(3):203–208. doi: 10.7326/0003-4819-109-3-203. [DOI] [PubMed] [Google Scholar]
  38. Fernie B. F., Gerin J. L. Immunochemical identification of viral and nonviral proteins of the respiratory syncytial virus virion. Infect Immun. 1982 Jul;37(1):243–249. doi: 10.1128/iai.37.1.243-249.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Fouillard L., Mouthon L., Laporte J. P., Isnard F., Stachowiak J., Aoudjhane M., Lucet J. C., Wolf M., Bricourt F., Douay L. Severe respiratory syncytial virus pneumonia after autologous bone marrow transplantation: a report of three cases and review. Bone Marrow Transplant. 1992 Feb;9(2):97–100. [PubMed] [Google Scholar]
  40. Freymuth F., Petitjean J., Pothier P., Brouard J., Norrby E. Prevalence of respiratory syncytial virus subgroups A and B in France from 1982 to 1990. J Clin Microbiol. 1991 Mar;29(3):653–655. doi: 10.1128/jcm.29.3.653-655.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Fulginiti V. A., Arthur J. H., Pearlman D. S., Kempe C. H. Altered reactivity to measles virus: local reactions following attenuated measles virus immunization in children who previously received a combination of inactivated and attenuated vaccines. Am J Dis Child. 1968 Jun;115(6):671–676. doi: 10.1001/archpedi.1968.02100010673006. [DOI] [PubMed] [Google Scholar]
  42. Fulginiti V. A., Eller J. J., Downie A. W., Kempe C. H. Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA. 1967 Dec 18;202(12):1075–1080. doi: 10.1001/jama.202.12.1075. [DOI] [PubMed] [Google Scholar]
  43. Fulginiti V. A., Eller J. J., Sieber O. F., Joyner J. W., Minamitani M., Meiklejohn G. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol. 1969 Apr;89(4):435–448. doi: 10.1093/oxfordjournals.aje.a120956. [DOI] [PubMed] [Google Scholar]
  44. GARDNER P. S., ELDERKIN F. M., WALL A. H. SEROLOGICAL STUDY OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS IN INFANCY AND CHILDHOOD. Br Med J. 1964 Dec 19;2(5424):1570–1573. doi: 10.1136/bmj.2.5424.1570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. García-Barreno B., Palomo C., Peñas C., Delgado T., Perez-Breña P., Melero J. A. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J Virol. 1989 Feb;63(2):925–932. doi: 10.1128/jvi.63.2.925-932.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Gimenez H. B., Cash P., Melvin W. T. Monoclonal antibodies to human respiratory syncytial virus and their use in comparison of different virus isolates. J Gen Virol. 1984 May;65(Pt 5):963–971. doi: 10.1099/0022-1317-65-5-963. [DOI] [PubMed] [Google Scholar]
  47. Gimenez H. B., Hardman N., Keir H. M., Cash P. Antigenic variation between human respiratory syncytial virus isolates. J Gen Virol. 1986 May;67(Pt 5):863–870. doi: 10.1099/0022-1317-67-5-863. [DOI] [PubMed] [Google Scholar]
  48. Glezen W. P., Paredes A., Allison J. E., Taber L. H., Frank A. L. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. 1981 May;98(5):708–715. doi: 10.1016/s0022-3476(81)80829-3. [DOI] [PubMed] [Google Scholar]
  49. Glezen W. P., Taber L. H., Frank A. L., Kasel J. A. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986 Jun;140(6):543–546. doi: 10.1001/archpedi.1986.02140200053026. [DOI] [PubMed] [Google Scholar]
  50. Graham B. S., Bunton L. A., Rowland J., Wright P. F., Karzon D. T. Respiratory syncytial virus infection in anti-mu-treated mice. J Virol. 1991 Sep;65(9):4936–4942. doi: 10.1128/jvi.65.9.4936-4942.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Graham B. S., Davis T. H., Tang Y. W., Gruber W. C. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum. Pediatr Res. 1993 Aug;34(2):167–172. doi: 10.1203/00006450-199308000-00013. [DOI] [PubMed] [Google Scholar]
  52. Groothuis J. R., Gutierrez K. M., Lauer B. A. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics. 1988 Aug;82(2):199–203. [PubMed] [Google Scholar]
  53. Groothuis J. R., Levin M. J., Rodriguez W., Hall C. B., Long C. E., Kim H. W., Lauer B. A., Hemming V. G. Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group. Antimicrob Agents Chemother. 1991 Jul;35(7):1469–1473. doi: 10.1128/aac.35.7.1469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Groothuis J. R., Simoes E. A., Levin M. J., Hall C. B., Long C. E., Rodriguez W. J., Arrobio J., Meissner H. C., Fulton D. R., Welliver R. C. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med. 1993 Nov 18;329(21):1524–1530. doi: 10.1056/NEJM199311183292102. [DOI] [PubMed] [Google Scholar]
  55. Gruber W. C., Wilson S. Z., Throop B. J., Wyde P. R. Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat. Pediatr Res. 1987 Mar;21(3):270–274. doi: 10.1203/00006450-198703000-00013. [DOI] [PubMed] [Google Scholar]
  56. HAMPARIAN V. V., KETLER A., HILLEMAN M. R., REILLY C. M., McCLELLAND L., CORNFELD D., STOKES J., Jr Studies of acute respiratory illnesses caused by respiratory syncytial virus. 1. Laboratory findings in 109 cases. Proc Soc Exp Biol Med. 1961 Apr;106:717–722. doi: 10.3181/00379727-106-26452. [DOI] [PubMed] [Google Scholar]
  57. Hall C. B., Douglas R. G., Jr Respiratory syncytial virus and influenza. Practical community surveillance. Am J Dis Child. 1976 Jun;130(6):615–620. doi: 10.1001/archpedi.1976.02120070041009. [DOI] [PubMed] [Google Scholar]
  58. Hall C. B., Geiman J. M., Douglas R. G., Jr, Meagher M. P. Control of nosocomial respiratory syncytial viral infections. Pediatrics. 1978 Nov;62(5):728–732. [PubMed] [Google Scholar]
  59. Hall C. B., Kopelman A. E., Douglas R. G., Jr, Geiman J. M., Meagher M. P. Neonatal respiratory syncytial virus infection. N Engl J Med. 1979 Feb 22;300(8):393–396. doi: 10.1056/NEJM197902223000803. [DOI] [PubMed] [Google Scholar]
  60. Hall C. B., Powell K. R., MacDonald N. E., Gala C. L., Menegus M. E., Suffin S. C., Cohen H. J. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med. 1986 Jul 10;315(2):77–81. doi: 10.1056/NEJM198607103150201. [DOI] [PubMed] [Google Scholar]
  61. Hall C. B., Walsh E. E., Long C. E., Schnabel K. C. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis. 1991 Apr;163(4):693–698. doi: 10.1093/infdis/163.4.693. [DOI] [PubMed] [Google Scholar]
  62. Hall C. B., Walsh E. E., Schnabel K. C., Long C. E., McConnochie K. M., Hildreth S. W., Anderson L. J. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis. 1990 Dec;162(6):1283–1290. doi: 10.1093/infdis/162.6.1283. [DOI] [PubMed] [Google Scholar]
  63. Harrington R. D., Hooton T. M., Hackman R. C., Storch G. A., Osborne B., Gleaves C. A., Benson A., Meyers J. D. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis. 1992 Jun;165(6):987–993. doi: 10.1093/infdis/165.6.987. [DOI] [PubMed] [Google Scholar]
  64. Hemming V. G., Fischer G. W., Prince G. A. Giant cell pneumonia due to respiratory syncytial virus. Arch Pathol Lab Med. 1985 Mar;109(3):213–213. [PubMed] [Google Scholar]
  65. Hemming V. G., Prince G. A., Horswood R. L., London W. J., Murphy B. R., Walsh E. E., Fischer G. W., Weisman L. E., Baron P. A., Chanock R. M. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model. J Infect Dis. 1985 Nov;152(5):1083–1087. doi: 10.1093/infdis/152.5.1083. [DOI] [PubMed] [Google Scholar]
  66. Hemming V. G., Prince G. A., London W. T., Baron P. A., Brown R., Chanock R. M. Topically administered immunoglobulin reduces pulmonary respiratory syncytial virus shedding in owl monkeys. Antimicrob Agents Chemother. 1988 Aug;32(8):1269–1270. doi: 10.1128/aac.32.8.1269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Hemming V. G., Prince G. A. Respiratory syncytial virus: babies and antibodies. Infect Agents Dis. 1992 Feb;1(1):24–32. [PubMed] [Google Scholar]
  68. Hemming V. G., Rodriguez W., Kim H. W., Brandt C. D., Parrott R. H., Burch B., Prince G. A., Baron P. A., Fink R. J., Reaman G. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother. 1987 Dec;31(12):1882–1886. doi: 10.1128/aac.31.12.1882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Henderson F. W., Collier A. M., Clyde W. A., Jr, Denny F. W. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med. 1979 Mar 8;300(10):530–534. doi: 10.1056/NEJM197903083001004. [DOI] [PubMed] [Google Scholar]
  70. Hertz M. I., Englund J. A., Snover D., Bitterman P. B., McGlave P. B. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine (Baltimore) 1989 Sep;68(5):269–281. doi: 10.1097/00005792-198909000-00002. [DOI] [PubMed] [Google Scholar]
  71. Hierholzer J. C., Hirsch M. S. Croup and pneumonia in human infants associated with a new strain of respiratory syncytial virus. J Infect Dis. 1979 Nov;140(5):826–828. doi: 10.1093/infdis/140.5.826. [DOI] [PubMed] [Google Scholar]
  72. Homa F. L., Brideau R. J., Lehman D. J., Thomsen D. R., Olmsted R. A., Wathen M. W. Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3. J Gen Virol. 1993 Sep;74(Pt 9):1995–1999. doi: 10.1099/0022-1317-74-9-1995. [DOI] [PubMed] [Google Scholar]
  73. JOHNSON K. M., BLOOM H. H., MUFSON M. A., CHANOCK R. M. Natural reinfection of adults by respiratory syncytial virus. Possible relation to mild upper respiratory disease. N Engl J Med. 1962 Jul 12;267:68–72. doi: 10.1056/NEJM196207122670204. [DOI] [PubMed] [Google Scholar]
  74. Johnson P. R., Jr, Olmsted R. A., Prince G. A., Murphy B. R., Alling D. W., Walsh E. E., Collins P. L. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol. 1987 Oct;61(10):3163–3166. doi: 10.1128/jvi.61.10.3163-3166.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Johnson R. A., Prince G. A., Suffin S. C., Horswood R. L., Chanock R. M. Respiratory syncytial virus infection in cyclophosphamide-treated cotton rats. Infect Immun. 1982 Jul;37(1):369–373. doi: 10.1128/iai.37.1.369-373.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. KRAVETZ H. M., KNIGHT V., CHANOCK R. M., MORRIS J. A., JOHNSON K. M., RIFKIND D., UTZ J. P. Respiratory syncytial virus. III. Production of illness and clinical observations in adult volunteers. JAMA. 1961 May 27;176:657–663. [PubMed] [Google Scholar]
  77. Kapikian A. Z., Mitchell R. H., Chanock R. M., Shvedoff R. A., Stewart C. E. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol. 1969 Apr;89(4):405–421. doi: 10.1093/oxfordjournals.aje.a120954. [DOI] [PubMed] [Google Scholar]
  78. Kim H. W., Arrobio J. O., Brandt C. D., Jeffries B. C., Pyles G., Reid J. L., Chanock R. M., Parrott R. H. Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol. 1973 Sep;98(3):216–225. doi: 10.1093/oxfordjournals.aje.a121550. [DOI] [PubMed] [Google Scholar]
  79. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969 Apr;89(4):422–434. doi: 10.1093/oxfordjournals.aje.a120955. [DOI] [PubMed] [Google Scholar]
  80. Kurlandsky L. E., French G., Webb P. M., Porter D. D. Fatal respiratory syncytial virus pneumonitis in a previously healthy child. Am Rev Respir Dis. 1988 Aug;138(2):468–472. doi: 10.1164/ajrccm/138.2.468. [DOI] [PubMed] [Google Scholar]
  81. Lamprecht C. L., Krause H. E., Mufson M. A. Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. J Infect Dis. 1976 Sep;134(3):211–217. doi: 10.1093/infdis/134.3.211. [DOI] [PubMed] [Google Scholar]
  82. Law B. J., De Carvalho V. Respiratory syncytial virus infections in hospitalized Canadian children: regional differences in patient populations and management practices. The Pediatric Investigators Collaborative Network on Infections in Canada. Pediatr Infect Dis J. 1993 Aug;12(8):659–663. [PubMed] [Google Scholar]
  83. MCCLELLAND L., HILLEMAN M. R., HAMPARIAN V. V., KETLER A., REILLY C. M., CORNFELD D., STOKES J., Jr Studies of acute respiratory illnesses caused by respiratory syncytial virus. 2. Epidemiology and assessment of importance. N Engl J Med. 1961 Jun 8;264:1169–1175. doi: 10.1056/NEJM196106082642301. [DOI] [PubMed] [Google Scholar]
  84. MacDonald N. E., Hall C. B., Suffin S. C., Alexson C., Harris P. J., Manning J. A. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med. 1982 Aug 12;307(7):397–400. doi: 10.1056/NEJM198208123070702. [DOI] [PubMed] [Google Scholar]
  85. McConnochie K. M., Hall C. B., Walsh E. E., Roghmann K. J. Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr. 1990 Jul;117(1 Pt 1):52–62. doi: 10.1016/s0022-3476(05)82443-6. [DOI] [PubMed] [Google Scholar]
  86. McIntosh E. D., De Silva L. M., Oates R. K. Clinical severity of respiratory syncytial virus group A and B infection in Sydney, Australia. Pediatr Infect Dis J. 1993 Oct;12(10):815–819. doi: 10.1097/00006454-199310000-00004. [DOI] [PubMed] [Google Scholar]
  87. McIntosh K., Masters H. B., Orr I., Chao R. K., Barkin R. M. The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis. 1978 Jul;138(1):24–32. doi: 10.1093/infdis/138.1.24. [DOI] [PubMed] [Google Scholar]
  88. McKay E., Higgins P., Tyrrell D., Pringle C. Immunogenicity and pathogenicity of temperature-sensitive modified respiratory syncytial virus in adult volunteers. J Med Virol. 1988 Aug;25(4):411–421. doi: 10.1002/jmv.1890250405. [DOI] [PubMed] [Google Scholar]
  89. Meissner H. C., Fulton D. R., Groothuis J. R., Geggel R. L., Marx G. R., Hemming V. G., Hougen T., Snydman D. R. Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin. Antimicrob Agents Chemother. 1993 Aug;37(8):1655–1658. doi: 10.1128/aac.37.8.1655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Moler F. W., Khan A. S., Meliones J. N., Custer J. R., Palmisano J., Shope T. C. Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience. Crit Care Med. 1992 Oct;20(10):1406–1413. doi: 10.1097/00003246-199210000-00008. [DOI] [PubMed] [Google Scholar]
  91. Monto A. S., Lim S. K. The Tecumseh study of respiratory illness. 3. Incidence and periodicity of respiratory syncytial virus and Mycoplasma pneumoniae infections. Am J Epidemiol. 1971 Sep;94(3):290–301. doi: 10.1093/oxfordjournals.aje.a121322. [DOI] [PubMed] [Google Scholar]
  92. Monto A. S., Ohmit S. Respiratory syncytial virus in a community population: circulation of subgroups A and B since 1965. J Infect Dis. 1990 Apr;161(4):781–783. doi: 10.1093/infdis/161.4.781. [DOI] [PubMed] [Google Scholar]
  93. Muelenaer P. M., Henderson F. W., Hemming V. G., Walsh E. E., Anderson L. J., Prince G. A., Murphy B. R. Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections. J Infect Dis. 1991 Jul;164(1):15–21. doi: 10.1093/infdis/164.1.15. [DOI] [PubMed] [Google Scholar]
  94. Mufson M. A., Akerlind-Stopner B., Orvell C., Belshe R. B., Norrby E. A single-season epidemic with respiratory syncytial virus subgroup B2 during 10 epidemic years, 1978 to 1988. J Clin Microbiol. 1991 Jan;29(1):162–165. doi: 10.1128/jcm.29.1.162-165.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Mufson M. A., Belshe R. B., Orvell C., Norrby E. Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections. J Clin Microbiol. 1987 Aug;25(8):1535–1539. doi: 10.1128/jcm.25.8.1535-1539.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Murphy B. R., Graham B. S., Prince G. A., Walsh E. E., Chanock R. M., Karzon D. T., Wright P. F. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol. 1986 Jun;23(6):1009–1014. doi: 10.1128/jcm.23.6.1009-1014.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Murphy B. R., Sotnikov A., Paradiso P. R., Hildreth S. W., Jenson A. B., Baggs R. B., Lawrence L., Zubak J. J., Chanock R. M., Beeler J. A. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease. Vaccine. 1989 Dec;7(6):533–540. doi: 10.1016/0264-410x(89)90278-8. [DOI] [PubMed] [Google Scholar]
  98. Muñoz J. L., McCarthy C. A., Clark M. E., Hall C. B. Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells. J Virol. 1991 Aug;65(8):4494–4497. doi: 10.1128/jvi.65.8.4494-4497.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Nadal D., Albini B., Schläpfer E., Chen C., Brodsky L., Ogra P. L. Tissue distribution of mucosal antibody-producing cells specific for respiratory syncytial virus in severe combined immune deficiency (SCID) mice engrafted with human tonsils. Clin Exp Immunol. 1991 Sep;85(3):358–364. doi: 10.1111/j.1365-2249.1991.tb05732.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Navas L., Wang E., de Carvalho V., Robinson J. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr. 1992 Sep;121(3):348–354. doi: 10.1016/s0022-3476(05)90000-0. [DOI] [PubMed] [Google Scholar]
  101. Ogilvie M. M., Vathenen A. S., Radford M., Codd J., Key S. Maternal antibody and respiratory syncytial virus infection in infancy. J Med Virol. 1981;7(4):263–271. doi: 10.1002/jmv.1890070403. [DOI] [PubMed] [Google Scholar]
  102. PARROTT R. H., VARGOSKO A. J., KIM H. W., CUMMING C., TURNER H., HUEBNER R. J., CHANOCK R. M. Respiratory syncytial virus. II. Serologic studies over a 34-month period of children with bronchiolitis, pneumonia, and minor respiratory diseases. JAMA. 1961 May 27;176:653–657. [PubMed] [Google Scholar]
  103. Piazza F. M., Johnson S. A., Ottolini M. G., Schmidt H. J., Darnell M. E., Hemming V. G., Prince G. A. Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small-particle aerosol. J Infect Dis. 1992 Dec;166(6):1422–1424. doi: 10.1093/infdis/166.6.1422. [DOI] [PubMed] [Google Scholar]
  104. Porter D. D., Muck K. B., Prince G. A. The age dependence of respiratory syncytial virus growth in ferret lung can be shown in organ and monolayer cultures. Clin Immunol Immunopathol. 1980 Mar;15(3):415–423. doi: 10.1016/0090-1229(80)90053-7. [DOI] [PubMed] [Google Scholar]
  105. Prince G. A., Hemming V. G., Horswood R. L., Baron P. A., Chanock R. M. Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats. J Virol. 1987 Jun;61(6):1851–1854. doi: 10.1128/jvi.61.6.1851-1854.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Prince G. A., Hemming V. G., Horswood R. L., Baron P. A., Murphy B. R., Chanock R. M. Mechanism of antibody-mediated viral clearance in immunotherapy of respiratory syncytial virus infection of cotton rats. J Virol. 1990 Jun;64(6):3091–3092. doi: 10.1128/jvi.64.6.3091-3092.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Prince G. A., Hemming V. G., Horswood R. L., Chanock R. M. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Res. 1985 Oct;3(3):193–206. doi: 10.1016/0168-1702(85)90045-0. [DOI] [PubMed] [Google Scholar]
  108. Prince G. A., Horswood R. L., Camargo E., Koenig D., Chanock R. M. Mechanisms of immunity to respiratory syncytial virus in cotton rats. Infect Immun. 1983 Oct;42(1):81–87. doi: 10.1128/iai.42.1.81-87.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Prince G. A., Horswood R. L., Chanock R. M. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J Virol. 1985 Sep;55(3):517–520. doi: 10.1128/jvi.55.3.517-520.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Prince G. A., Jenson A. B., Hemming V. G., Murphy B. R., Walsh E. E., Horswood R. L., Chanock R. M. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus. J Virol. 1986 Mar;57(3):721–728. doi: 10.1128/jvi.57.3.721-728.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Prince G. A., Jenson A. B., Horswood R. L., Camargo E., Chanock R. M. The pathogenesis of respiratory syncytial virus infection in cotton rats. Am J Pathol. 1978 Dec;93(3):771–791. [PMC free article] [PubMed] [Google Scholar]
  112. Prince G. A., Porter D. D. The pathogenesis of respiratory syncytial virus infection in infant ferrets. Am J Pathol. 1976 Feb;82(2):339–352. [PMC free article] [PubMed] [Google Scholar]
  113. Prince G. A., Suffin S. C., Prevar D. A., Camargo E., Sly D. L., London W. T., Chanock R. M. Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants. Infect Immun. 1979 Dec;26(3):1009–1013. doi: 10.1128/iai.26.3.1009-1013.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. REILLY C. M., STOKES J., Jr, McCLELLAND L., CORNFELD D., HAMPARIAN V. V., KETLER A., HILLEMAN M. R. Studies of acute respiratory illnesses caused by respiratory syncytial virus. 3. Clinical and laboratory findings. N Engl J Med. 1961 Jun 8;264:1176–1182. doi: 10.1056/NEJM196106082642302. [DOI] [PubMed] [Google Scholar]
  115. Richardson-Wyatt L. S., Belshe R. B., London W. T., Sly D. L., Camargo E., Chanock R. M. Respiratory syncytial virus antibodies in nonhuman primates and domestic animals. Lab Anim Sci. 1981 Aug;31(4):413–415. [PubMed] [Google Scholar]
  116. Richardson L. S., Belshe R. B., London W. T., Sly D. L., Prevar D. A., Camargo E., Chanock R. M. Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness. J Med Virol. 1978;3(2):91–100. doi: 10.1002/jmv.1890030202. [DOI] [PubMed] [Google Scholar]
  117. Siber G. R., Leombruno D., Leszczynski J., McIver J., Bodkin D., Gonin R., Thompson C. M., Walsh E. E., Piedra P. A., Hemming V. G. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. J Infect Dis. 1994 Jun;169(6):1368–1373. doi: 10.1093/infdis/169.6.1368. [DOI] [PubMed] [Google Scholar]
  118. Siber G. R., Leszcynski J., Pena-Cruz V., Ferren-Gardner C., Anderson R., Hemming V. G., Walsh E. E., Burns J., McIntosh K., Gonin R. Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. J Infect Dis. 1992 Mar;165(3):456–463. doi: 10.1093/infdis/165.3.456. [DOI] [PubMed] [Google Scholar]
  119. Siqueira M. M., Nascimento J. P., Anderson L. J. Antigenic characterization of respiratory syncytial virus group A and B isolates in Rio de Janeiro, Brazil. J Clin Microbiol. 1991 Mar;29(3):557–559. doi: 10.1128/jcm.29.3.557-559.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Sriskandan S., Shaunak S. Respiratory syncytial virus infection in an adult with AIDS. Clin Infect Dis. 1993 Dec;17(6):1065–1065. doi: 10.1093/clinids/17.6.1065. [DOI] [PubMed] [Google Scholar]
  121. Storch G. A., Anderson L. J., Park C. S., Tsou C., Dohner D. E. Antigenic and genomic diversity within group A respiratory syncytial virus. J Infect Dis. 1991 Apr;163(4):858–861. doi: 10.1093/infdis/163.4.858. [DOI] [PubMed] [Google Scholar]
  122. Stretton M., Ajizian S. J., Mitchell I., Newth C. J. Intensive care course and outcome of patients infected with respiratory syncytial virus. Pediatr Pulmonol. 1992 Jul;13(3):143–150. doi: 10.1002/ppul.1950130304. [DOI] [PubMed] [Google Scholar]
  123. Suffin S. C., Prince G. A., Muck K. B., Porter D. D. Immunoprophylaxis of respiratory syncytial virus infection in the infant ferret. J Immunol. 1979 Jul;123(1):10–14. [PubMed] [Google Scholar]
  124. Sullender W. M., Mufson M. A., Anderson L. J., Wertz G. W. Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses. J Virol. 1991 Oct;65(10):5425–5434. doi: 10.1128/jvi.65.10.5425-5434.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Suto T., Yano N., Ikeda M., Miyamoto M., Takai S., Shigeta S., Hinuma Y., Ishida N. Respiratory syncytial virus infection and its serologic epidemiology. Am J Epidemiol. 1965 Nov;82(3):211–224. doi: 10.1093/oxfordjournals.aje.a120545. [DOI] [PubMed] [Google Scholar]
  126. Taylor C. E., Craft A. W., Kernahan J., Millman R., Reid M. M., Scott R., Toms G. L. Local antibody production and respiratory syncytial virus infection in children with leukaemia. J Med Virol. 1990 Apr;30(4):277–281. doi: 10.1002/jmv.1890300409. [DOI] [PubMed] [Google Scholar]
  127. Taylor G., Furze J., Tempest P. R., Bremner P., Carr F. J., Harris W. J. Humanised monoclonal antibody to respiratory syncytial virus. Lancet. 1991 Jun 8;337(8754):1411–1412. doi: 10.1016/0140-6736(91)93091-m. [DOI] [PubMed] [Google Scholar]
  128. Taylor G., Stott E. J., Bew M., Fernie B. F., Cote P. J., Collins A. P., Hughes M., Jebbett J. Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology. 1984 May;52(1):137–142. [PMC free article] [PubMed] [Google Scholar]
  129. Taylor G., Stott E. J., Hughes M., Collins A. P. Respiratory syncytial virus infection in mice. Infect Immun. 1984 Feb;43(2):649–655. doi: 10.1128/iai.43.2.649-655.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Thomas E., Margach M. J., Orvell C., Morrison B., Wilson E. Respiratory syncytial virus subgroup B dominance during one winter season between 1987 and 1992 in Vancouver, Canada. J Clin Microbiol. 1994 Jan;32(1):238–242. doi: 10.1128/jcm.32.1.238-242.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Tristram D. A., Welliver R. C., Mohar C. K., Hogerman D. A., Hildreth S. W., Paradiso P. Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old. J Infect Dis. 1993 Jan;167(1):191–195. doi: 10.1093/infdis/167.1.191. [DOI] [PubMed] [Google Scholar]
  132. Tsutsumi H., Onuma M., Suga K., Honjo T., Chiba Y., Chiba S., Ogra P. L. Occurrence of respiratory syncytial virus subgroup A and B strains in Japan, 1980 to 1987. J Clin Microbiol. 1988 Jun;26(6):1171–1174. doi: 10.1128/jcm.26.6.1171-1174.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. WULFF H., KIDD P., WENNER H. A. RESPIRATORY SYNCYTIAL VIRUS: OBSERVATIONS ON ANTIGENIC HETEROGENEITY. Proc Soc Exp Biol Med. 1964 Jan;115:240–243. doi: 10.3181/00379727-115-28880. [DOI] [PubMed] [Google Scholar]
  134. Walsh E. E., Brandriss M. W., Schlesinger J. J. Purification and characterization of the respiratory syncytial virus fusion protein. J Gen Virol. 1985 Mar;66(Pt 3):409–415. doi: 10.1099/0022-1317-66-3-409. [DOI] [PubMed] [Google Scholar]
  135. Walsh E. E., Hall C. B., Briselli M., Brandriss M. W., Schlesinger J. J. Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. J Infect Dis. 1987 Jun;155(6):1198–1204. doi: 10.1093/infdis/155.6.1198. [DOI] [PubMed] [Google Scholar]
  136. Walsh E. E., Schlesinger J. J., Brandriss M. W. Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus. J Gen Virol. 1984 Apr;65(Pt 4):761–767. doi: 10.1099/0022-1317-65-4-761. [DOI] [PubMed] [Google Scholar]
  137. Ward K. A., Lambden P. R., Ogilvie M. M., Watt P. J. Antibodies to respiratory syncytial virus polypeptides and their significance in human infection. J Gen Virol. 1983 Sep;64(Pt 9):1867–1876. doi: 10.1099/0022-1317-64-9-1867. [DOI] [PubMed] [Google Scholar]
  138. Waris M. Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B. J Infect Dis. 1991 Mar;163(3):464–469. doi: 10.1093/infdis/163.3.464. [DOI] [PubMed] [Google Scholar]
  139. Wathen M. W., Brideau R. J., Thomsen D. R. Immunization of cotton rats with the human respiratory syncytial virus F glycoprotein produced using a baculovirus vector. J Infect Dis. 1989 Feb;159(2):255–264. doi: 10.1093/infdis/159.2.255. [DOI] [PubMed] [Google Scholar]
  140. Wathen M. W., Brideau R. J., Thomsen D. R., Murphy B. R. Characterization of a novel human respiratory syncytial virus chimeric FG glycoprotein expressed using a baculovirus vector. J Gen Virol. 1989 Oct;70(Pt 10):2625–2635. doi: 10.1099/0022-1317-70-10-2625. [DOI] [PubMed] [Google Scholar]
  141. Wong D. T., Rosenband M., Hovey K., Ogra P. L. Respiratory syncytial virus infection in immunosuppressed animals: implications in human infection. J Med Virol. 1985 Dec;17(4):359–370. doi: 10.1002/jmv.1890170408. [DOI] [PubMed] [Google Scholar]
  142. Wright P. F., Belshe R. B., Kim H. W., Van Voris L. P., Chanock R. M. Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. Infect Immun. 1982 Jul;37(1):397–400. doi: 10.1128/iai.37.1.397-400.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Wright P. F., Shinozaki T., Fleet W., Sell S. H., Thompson J., Karzon D. T. Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants. J Pediatr. 1976 Jun;88(6):931–936. doi: 10.1016/s0022-3476(76)81044-x. [DOI] [PubMed] [Google Scholar]
  144. Wyde P. R., Sun C. S., Knight V. Replication of respiratory syncytial virus in lungs of immunodeficient mice. J Reticuloendothel Soc. 1983 Aug;34(2):125–129. [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES